Medical Marijuana, Inc. (MJNA)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Medical Marijuana Net Income (Quarterly) : -0.0209M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0209M |
| March 31, 2026 | 0.1669M |
| December 31, 2025 | -1.256M |
| September 30, 2025 | 0.0127M |
| June 30, 2025 | -0.1282M |
| March 31, 2025 | 0.4356M |
| December 31, 2024 | -0.4599M |
| September 30, 2024 | 0.0995M |
| June 30, 2024 | -0.4943M |
| March 31, 2024 | 0.2131M |
| December 31, 2023 | -3.114M |
| September 30, 2023 | -0.8491M |
| June 30, 2023 | 0.4055M |
| March 31, 2023 | -1.526M |
| December 31, 2022 | -1.992M |
| September 30, 2022 | -2.19M |
| June 30, 2022 | -11.16M |
| March 31, 2022 | -0.0125M |
| December 31, 2021 | -3.836M |
| September 30, 2021 | -11.77M |
| June 30, 2021 | 7.057M |
| March 31, 2021 | 3.778M |
| December 31, 2020 | -14.59M |
| September 30, 2020 | -0.1067M |
| June 30, 2020 | 9.700M |
| Date | Value |
|---|---|
| March 31, 2020 | -90.78M |
| December 31, 2019 | 92.71M |
| September 30, 2019 | -2.836M |
| June 30, 2019 | -15.01M |
| March 31, 2019 | 9.538M |
| December 31, 2018 | -24.59M |
| September 30, 2018 | -22.38M |
| June 30, 2018 | -21.07M |
| March 31, 2018 | -134.59M |
| December 31, 2017 | -134.97M |
| September 30, 2017 | -2.959M |
| June 30, 2017 | -2.045M |
| March 31, 2017 | -2.223M |
| December 31, 2016 | -6.520M |
| September 30, 2016 | -4.287M |
| June 30, 2016 | -4.005M |
| March 31, 2016 | -11.10M |
| December 31, 2015 | 39.80M |
| September 30, 2015 | -7.300M |
| June 30, 2015 | -5.652M |
| March 31, 2015 | -0.879M |
| December 31, 2014 | -3.998M |
| September 30, 2014 | 0.3356M |
| June 30, 2014 | -1.080M |
| March 31, 2014 | 0.0694M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ZeroStack Corp. | -24.62M |
| Interpace Biosciences, Inc. | 0.266M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0214M |
| Stella Diagnostics, Inc. | -0.978M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.342M |
| Total Expenses (Quarterly) | 2.362M |
| Enterprise Value | 3.821M |
| Gross Profit Margin (Quarterly) | 83.04% |
| Profit Margin (Quarterly) | -0.89% |
| Earnings Yield | -100.0% |
| Normalized Earnings Yield | -100.00 |